Skip to main content

Year: 2025

Lupaka Applies for Warrant Extension

VANCOUVER, British Columbia, Oct. 10, 2025 (GLOBE NEWSWIRE) — Lupaka Gold Corp. (“Lupaka” or the “Company”) (TSX-V: LPK, FRA: LQP) announces that the Company intends to amend the terms of 2,000,000 outstanding common share purchase warrants of the Company (the “Warrants“) that are set to expire October 28, 2025. The Company is applying to the TSX Venture Exchange (the “TSXV“) to extend the expiry date of the 2,000,000 Warrants to October 28, 2026. The 2,000,000 Warrants were originally issued on October 28, 2022 as part of the units issued under a private placement. The Warrants have an exercise price of $0.25 per share for a period of 36 months. Since the issuance, no warrants have been exercised. All other terms and conditions of the Warrants will remain the same. The warrant extension is subject to the...

Continue reading

Ignitis Renewables takes over full control of the Curonian Nord offshore wind farm

AB “Ignitis grupė” (hereinafter – the Group) informs that following the National Energy Regulatory Council’s (hereinafter – NERC) approval on 10 October, UAB “Ignitis renewables” (hereinafter – Ignitis Renewables) has signed a sale and purchase agreement with OW Offshore, S.L. (hereinafter – Ocean Winds) for the acquisition of 49% shares in UAB “Offshore wind farm 1”, the company developing the Curonian Nord offshore wind project. The application to change the shareholder structure was submitted to NERC by UAB “Offshore wind farm 1” on 30 September. Upon closing the transaction, Ignitis Renewables will acquire 49% of the shares at a nominal price. Ignitis Renewables will also secure the project-related work, research data and intellectual property by reimbursing Ocean Winds for its directly incurred project-related costs. This change will...

Continue reading

Ignitis Renewables takes over full control of the Curonian Nord offshore wind farm

AB “Ignitis grupė” (hereinafter – the Group) informs that following the National Energy Regulatory Council’s (hereinafter – NERC) approval on 10 October, UAB “Ignitis renewables” (hereinafter – Ignitis Renewables) has signed a sale and purchase agreement with OW Offshore, S.L. (hereinafter – Ocean Winds) for the acquisition of 49% shares in UAB “Offshore wind farm 1”, the company developing the Curonian Nord offshore wind project. The application to change the shareholder structure was submitted to NERC by UAB “Offshore wind farm 1” on 30 September. Upon closing the transaction, Ignitis Renewables will acquire 49% of the shares at a nominal price. Ignitis Renewables will also secure the project-related work, research data and intellectual property by reimbursing Ocean Winds for its directly incurred project-related costs. This change will...

Continue reading

MAXIMA GRUPĖ Borrows EUR 260 Million from SEB and ING Banks to Redeem Bonds

MAXIMA GRUPĖ Borrows EUR 260 Million from SEB and ING Banks to Redeem Bonds MAXIMA GRUPĖ, UAB (hereinafter – MAXIMA GRUPĖ) announces that it has signed a short-term 2-year financing agreement for a total amount of EUR 260 million with Skandinaviska Enskilda Banken AB, AB SEB bankas (together EUR 130 million) and ING Belgium SA/NV (EUR 130 million). The funds received from the banks will be used for the early redemption of the MAXIMA GRUPĖ issued long-term bonds and for its related expenses. The credit agreement concluded with the banks is not secured by performance guarantees or any other pledged assets. “Through this agreement, we are extending our long-term partnership with SEB, one of the largest banks in the Baltic region. We are also pleased to welcome ING, an international banking and financial services provider and one of the largest...

Continue reading

NOTICE OF EXERCISE OF MAKE WHOLE CALL OPTION

NOTICE OF EXERCISE OF MAKE WHOLE CALL OPTION MAXIMA GRUPE, UAB(the “Issuer”)1 €240,000,000 6.250 per cent. Notes due 2027(the “Notes”) (ISIN: XS2485155464) (Common Code: 248515546) 10 October 2025 We refer to the terms and conditions of the Notes (the “Conditions“). Capitalised terms used in this notice that are not otherwise defined have the meaning given to them in the Conditions. Pursuant to Condition 6(e) (Redemption at the Option of the Issuer (Make Whole)) of the Conditions, the Issuer hereby gives notice to the holders of the Notes that it has elected to redeem all the Notes on 27 October 2025 (the “Make Whole Optional Redemption Date“) at the Make Whole Redemption Price together with interest accrued to, but excluding, and unpaid to the Make Whole Optional Redemption Date. The Issuer...

Continue reading

Bitfarms Converts Macquarie Debt Facility to $300M Project Financing and Draws Additional $50M to Accelerate HPC/AI Development at Panther Creek Campus

-$300 million facility to fund Phase 1 of Panther Creek data center development with energization expected by YE 2026--On track to break ground on Panther Creek data center in Q4 2025- This news release constitutes a “designated news release” for the purposes of the Company’s second amended and restated prospectus supplement dated December 17, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO, Ontario and NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) — Bitfarms Ltd. (Nasdaq/TSX: BITF) (the “Company”), a North American energy and digital infrastructure company, has converted its previously announced private debt facility for up to $300 million from Macquarie Group’s Commodities and Global Markets business (“Macquarie”), to an up to $300 million project-specific financing facility for the development of its...

Continue reading

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million

PIPE financing included participation from leading healthcare-focused institutional investors including AIGH Capital Management, Soleus Capital, Nantahala Capital, Diadema Partners, Stonepine Capital Management, ADAR1 Capital Management, and Velan Capital, among others ASHBURN, Va., Oct. 10, 2025 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it has entered into a securities purchase agreement with new healthcare focused institutional investors with the potential to raise up to $104.5 million in gross proceeds, including initial upfront funding of $16.5 million and up to an additional $88.0 million upon the potential cash exercise of accompanying warrants at the election of the...

Continue reading

Zacks Small-Cap Research Initiates Coverage on NewGen

BANGKOK, Oct. 10, 2025 (GLOBE NEWSWIRE) — NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that Zacks Small-Cap Research (“Zacks”) has initiated equity research coverage on the Company. The full equity research report is available on the Zacks website here. About NewGenNewGenIVF Group is a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through three strategic business divisions that leverage cutting-edge...

Continue reading

ASP Isotopes Inc. to host Institutional Investor Access Event in South Africa from November 11 – 13, 2025

*** Limited places remain available for institutional investors for this previously announced Investor Access Event *** WASHINGTON, Oct. 10, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it will host an Institutional Investor Access Event in South Africa from November 11-13, 2025. **There is also the possibility of adding an extra day to the trip and visiting the Renergen Virginia Gas Project on November 14th – please let us know if you are also interested in attending that day too. (subject to numbers)** All investors are invited to request a registration to attend the Institutional Investor Access Event. ASP...

Continue reading

ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED

PALM BEACH GARDENS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) — ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV) today announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie stockholders voted to approve the acquisition of ZimVie by an affiliate of ARCHIMED (the “Merger”) pursuant to the terms and conditions of the Agreement and Plan of Merger, dated as of July 20, 2025 (the “Merger Agreement”). The parties now expect the Merger to close on October 20, 2025, subject to the satisfaction of all conditions in the Merger Agreement. About ZimVie ZimVie is a global life sciences leader in the dental implant market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.